Mariana Murea1, Fang-Chi Hsu2, Amanda J Cox3, Christina E Hugenschmidt4, Jianzhao Xu3, Jeremy N Adams5, Laura M Raffield6, Christopher T Whitlow7, Joseph A Maldjian7, Donald W Bowden3, Barry I Freedman8. 1. Internal Medicine-Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 2. Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA. 3. Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA. 4. Internal Medicine-Geriatrics and Gerontology, Wake Forest School of Medicine, Winston-Salem, NC, USA. 5. Molecular Genetics and Genomics, Wake Forest School of Medicine, Winston-Salem, NC, USA. 6. Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA. 7. Radiologic Sciences and Advanced NeuroScience Imaging (ANSIR) Laboratory, Wake Forest School of Medicine, Winston-Salem, NC, USA. 8. Internal Medicine-Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
BACKGROUND: Advanced chronic kidney disease (CKD) is associated with altered cerebral structure and function. Relationships between mild-to-moderate CKD and brain morphology and cognitive performance were evaluated in European Americans (EAs). METHODS: A total of 478 EAs with estimated glomerular filtration rate (eGFR) >45 mL/min/1.73 m(2) and urine albumin:creatinine ratio (UACR) < 300 mg/g, most with type 2 diabetes (T2D), were included. Measures of total intracranial volume (TICV), cerebrospinal fluid volume, total white matter volume (TWMV), total gray matter volume (TGMV), total white matter lesion volume (TWMLV), hippocampal white matter volume (HWMV) and hippocampal gray matter volume (HGMV) were obtained with magnetic resonance imaging. Cognitive testing included memory (Rey Auditory Visual Learning Test), global cognition (Modified Mini-Mental State Examination) and executive function (Stroop Task, Semantic Fluency, Digit Symbol Substitution Test). Associations with CKD were assessed using log-transformed eGFR and UACR, adjusted for age, sex, body mass index, smoking, hemoglobin A1c, blood pressure, diabetes duration, cardiovascular disease and education. RESULTS: Participants were 55.2% female, 78.2% had T2D; mean ± SD age 67.6 ± 9.0 years, T2D duration 16.4 ± 6.5 years, eGFR 92.0 ± 22.3 mL/min/1.73 m(2) and UACR 23.8 ± 39.6 mg/g. In adjusted models, eGFR was negatively associated with TICV only in participants with T2D [parameter estimate (β): -72.2, P = 0.002]. In non-diabetic participants, inverse relationships were observed between eGFR and HGMV (β: -1.0, P = 0.03) and UACR and normalized TWMLV (β: -0.2, P = 0.03). Kidney function and albuminuria did not correlate with cognitive testing. CONCLUSIONS: In EAs with mild CKD enriched for T2D, brain structure and cognitive performance were generally not impacted. Longitudinal studies are necessary to determine when cerebral structural changes and cognitive dysfunction develop with progressive CKD in EAs.
BACKGROUND: Advanced chronic kidney disease (CKD) is associated with altered cerebral structure and function. Relationships between mild-to-moderate CKD and brain morphology and cognitive performance were evaluated in European Americans (EAs). METHODS: A total of 478 EAs with estimated glomerular filtration rate (eGFR) >45 mL/min/1.73 m(2) and urine albumin:creatinine ratio (UACR) < 300 mg/g, most with type 2 diabetes (T2D), were included. Measures of total intracranial volume (TICV), cerebrospinal fluid volume, total white matter volume (TWMV), total gray matter volume (TGMV), total white matter lesion volume (TWMLV), hippocampal white matter volume (HWMV) and hippocampal gray matter volume (HGMV) were obtained with magnetic resonance imaging. Cognitive testing included memory (Rey Auditory Visual Learning Test), global cognition (Modified Mini-Mental State Examination) and executive function (Stroop Task, Semantic Fluency, Digit Symbol Substitution Test). Associations with CKD were assessed using log-transformed eGFR and UACR, adjusted for age, sex, body mass index, smoking, hemoglobin A1c, blood pressure, diabetes duration, cardiovascular disease and education. RESULTS:Participants were 55.2% female, 78.2% had T2D; mean ± SD age 67.6 ± 9.0 years, T2D duration 16.4 ± 6.5 years, eGFR 92.0 ± 22.3 mL/min/1.73 m(2) and UACR 23.8 ± 39.6 mg/g. In adjusted models, eGFR was negatively associated with TICV only in participants with T2D [parameter estimate (β): -72.2, P = 0.002]. In non-diabeticparticipants, inverse relationships were observed between eGFR and HGMV (β: -1.0, P = 0.03) and UACR and normalized TWMLV (β: -0.2, P = 0.03). Kidney function and albuminuria did not correlate with cognitive testing. CONCLUSIONS: In EAs with mild CKD enriched for T2D, brain structure and cognitive performance were generally not impacted. Longitudinal studies are necessary to determine when cerebral structural changes and cognitive dysfunction develop with progressive CKD in EAs.
Authors: Paul A Nyquist; Murat S Bilgel; Rebecca Gottesman; Lisa R Yanek; Taryn F Moy; Lewis C Becker; Jennifer Cuzzocreo; Jerry Prince; David M Yousem; Diane M Becker; Brian G Kral; Dhananjay Vaidya Journal: Cerebrovasc Dis Date: 2014-03-25 Impact factor: 2.762
Authors: Joshua I Barzilay; Peggy Gao; Martin O'Donnell; Johannes F E Mann; Craig Anderson; Robert Fagard; Jeffrey Probstfield; Gilles R Dagenais; Koon Teo; Salim Yusuf Journal: Arch Intern Med Date: 2011-01-24
Authors: Brooke C Schneider; Alden L Gross; Katherine J Bangen; Jeannine C Skinner; Andreana Benitez; M Maria Glymour; Bonnie C Sachs; Regina A Shih; Shannon Sisco; Jennifer J Manly; José A Luchsinger Journal: J Gerontol B Psychol Sci Soc Sci Date: 2014-05-12 Impact factor: 4.077
Authors: Marc M H Hermans; Ronald M A Henry; Jaqueline M Dekker; Giel Nijpels; Rob J Heine; Coen D A Stehouwer Journal: J Hypertens Date: 2008-04 Impact factor: 4.844
Authors: Anne M Murray; Joshua I Barzilay; James F Lovato; Jeff D Williamson; Michael E Miller; Santica Marcovina; Lenore J Launer Journal: Diabetes Care Date: 2011-06-29 Impact factor: 19.112
Authors: C Jongen; J van der Grond; L J Kappelle; G J Biessels; M A Viergever; J P W Pluim Journal: Diabetologia Date: 2007-05-11 Impact factor: 10.122
Authors: Prashanthi Vemuri; David S Knopman; Clifford R Jack; Emily S Lundt; Stephen D Weigand; Samantha M Zuk; Kaely B Thostenson; Robert I Reid; Kejal Kantarci; Yelena Slinin; Kamakshi Lakshminarayan; Cynthia S Davey; Anne Murray Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Barry I Freedman; Kaycee M Sink; Christina E Hugenschmidt; Timothy M Hughes; Jeff D Williamson; Christopher T Whitlow; Nicholette D Palmer; Michael E Miller; Laura C Lovato; Jianzhao Xu; S Carrie Smith; Lenore J Launer; Joshua I Barzilay; Robert M Cohen; Mark D Sullivan; R Nick Bryan; Benjamin C Wagner; Donald W Bowden; Joseph A Maldjian; Jasmin Divers Journal: Am J Kidney Dis Date: 2017-06-23 Impact factor: 8.860
Authors: Joshua I Barzilay; Timothy M Morgan; Anne M Murray; R Nick Bryan; Jeff D Williamson; Adrian Schnall; Lenore J Launer Journal: J Gerontol A Biol Sci Med Sci Date: 2015-11-19 Impact factor: 6.053
Authors: Behrouz Saghafi; Prabhat Garg; Benjamin C Wagner; S Carrie Smith; Jianzhao Xu; Ananth J Madhuranthakam; Youngkyoo Jung; Jasmin Divers; Barry I Freedman; Joseph A Maldjian; Albert Montillo Journal: Deep Learn Med Image Anal Multimodal Learn Clin Decis Support (2017) Date: 2017-09-09